LONG-LASTING PHARMACEUTICAL FORMULATION
PROBLEM TO BE SOLVED: To provide a safe and effective long-lasting pharmaceutical formulation.SOLUTION: The present invention provides a long-lasting therapeutic formulation and a method for the use thereof. The formulation comprises a genetically modified micro-organ that comprises a vector compris...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PEARLMAN ANDREW L |
| description | PROBLEM TO BE SOLVED: To provide a safe and effective long-lasting pharmaceutical formulation.SOLUTION: The present invention provides a long-lasting therapeutic formulation and a method for the use thereof. The formulation comprises a genetically modified micro-organ that comprises a vector comprising a nucleic acid sequence operably linked to one or more regulatory sequences. Here, the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon-α.SELECTED DRAWING: Figure 1
【課題】安全で効果的な長期持続性の医薬製剤を提供する。【解決手段】本発明は、長期持続性の治療用製剤とそれらの使用の方法へ向けられ、ここで該製剤は、１以上の調節配列へ機能可能的に連結した核酸配列を含むベクターを含む遺伝子修飾された微小器官を含み、ここで核酸配列は、エリスロポエチン又はインターフェロンαのような治療用ポリペプチドをコードする。【選択図】図１ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2017048231A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2017048231A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2017048231A3</originalsourceid><addsrcrecordid>eNrjZFD38fdz1_VxDA7x9HNXCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBobmBiYWRsaGjsZEKQIARV0kfA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LONG-LASTING PHARMACEUTICAL FORMULATION</title><source>esp@cenet</source><creator>PEARLMAN ANDREW L</creator><creatorcontrib>PEARLMAN ANDREW L</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a safe and effective long-lasting pharmaceutical formulation.SOLUTION: The present invention provides a long-lasting therapeutic formulation and a method for the use thereof. The formulation comprises a genetically modified micro-organ that comprises a vector comprising a nucleic acid sequence operably linked to one or more regulatory sequences. Here, the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon-α.SELECTED DRAWING: Figure 1
【課題】安全で効果的な長期持続性の医薬製剤を提供する。【解決手段】本発明は、長期持続性の治療用製剤とそれらの使用の方法へ向けられ、ここで該製剤は、１以上の調節配列へ機能可能的に連結した核酸配列を含むベクターを含む遺伝子修飾された微小器官を含み、ここで核酸配列は、エリスロポエチン又はインターフェロンαのような治療用ポリペプチドをコードする。【選択図】図１</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170309&DB=EPODOC&CC=JP&NR=2017048231A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170309&DB=EPODOC&CC=JP&NR=2017048231A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PEARLMAN ANDREW L</creatorcontrib><title>LONG-LASTING PHARMACEUTICAL FORMULATION</title><description>PROBLEM TO BE SOLVED: To provide a safe and effective long-lasting pharmaceutical formulation.SOLUTION: The present invention provides a long-lasting therapeutic formulation and a method for the use thereof. The formulation comprises a genetically modified micro-organ that comprises a vector comprising a nucleic acid sequence operably linked to one or more regulatory sequences. Here, the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon-α.SELECTED DRAWING: Figure 1
【課題】安全で効果的な長期持続性の医薬製剤を提供する。【解決手段】本発明は、長期持続性の治療用製剤とそれらの使用の方法へ向けられ、ここで該製剤は、１以上の調節配列へ機能可能的に連結した核酸配列を含むベクターを含む遺伝子修飾された微小器官を含み、ここで核酸配列は、エリスロポエチン又はインターフェロンαのような治療用ポリペプチドをコードする。【選択図】図１</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD38fdz1_VxDA7x9HNXCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBobmBiYWRsaGjsZEKQIARV0kfA</recordid><startdate>20170309</startdate><enddate>20170309</enddate><creator>PEARLMAN ANDREW L</creator><scope>EVB</scope></search><sort><creationdate>20170309</creationdate><title>LONG-LASTING PHARMACEUTICAL FORMULATION</title><author>PEARLMAN ANDREW L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2017048231A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PEARLMAN ANDREW L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PEARLMAN ANDREW L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LONG-LASTING PHARMACEUTICAL FORMULATION</title><date>2017-03-09</date><risdate>2017</risdate><abstract>PROBLEM TO BE SOLVED: To provide a safe and effective long-lasting pharmaceutical formulation.SOLUTION: The present invention provides a long-lasting therapeutic formulation and a method for the use thereof. The formulation comprises a genetically modified micro-organ that comprises a vector comprising a nucleic acid sequence operably linked to one or more regulatory sequences. Here, the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon-α.SELECTED DRAWING: Figure 1
【課題】安全で効果的な長期持続性の医薬製剤を提供する。【解決手段】本発明は、長期持続性の治療用製剤とそれらの使用の方法へ向けられ、ここで該製剤は、１以上の調節配列へ機能可能的に連結した核酸配列を含むベクターを含む遺伝子修飾された微小器官を含み、ここで核酸配列は、エリスロポエチン又はインターフェロンαのような治療用ポリペプチドをコードする。【選択図】図１</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2017048231A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | LONG-LASTING PHARMACEUTICAL FORMULATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A04%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PEARLMAN%20ANDREW%20L&rft.date=2017-03-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2017048231A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |